Last reviewed · How we verify

NCT04359875: COVIQuest

A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment

Completed NA Last updated 30 December 2025
What this trial tests

NA trial testing Phone-call screening and management by a medical student/general practitioner tandem in Cardiovascular Diseases in 22,000 participants. Completed in 31 December 2020.

Timeline
30 April 2020
Primary endpoint
30 June 2020
31 December 2020

Quick facts

Lead sponsorUniversity Hospital, Tours
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment22,000
Start date30 April 2020
Primary completion30 June 2020
Estimated completion31 December 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Tours

Who can join

Adults 18 to 110, any sex, with Cardiovascular Diseases or Mental Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Following the announcement of the containment of the population due to the COVID-19 epidemic on March 17, 2020 in France, a notable decrease in the number of consultations in general practice was reported. Patients no longer contact their general practitioner, including those with regular follow-up for one or more chronic conditions. This observation raised worries since it could lead to delay or failure in detecting decompensations / complications of these chronic conditions by a lack of recourse to care. Thus, an urgent message from the National Health Department (Direction Générale de la Santé - DGS) was adressed on April 8, 2020 to the health professionals regarding the organization of care aside from COVID-19. The main recommendation was "that the personal physician or the corresponding specialist should contact the most fragile patients with chronic condition to ensure follow-up and detect any risk of decompensation ". Such fragile patients are in great numbers, up to more than 200 for an average general practitioner. Therefore, although this recommendation is regarded as "essential in view of the health needs of the population", it will prove quite difficult to follow without the help of a skilled external assistance that can be quickly mobilized.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Impact of a phone call with a medical student/general practitioner team on morbidity of chronic patients during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trial.
    Dibao-Dina C, Léger J, Ettori-Ajasse I, Boivin E, et al · · 2022 · cited 2× · PMID 35902188 · DOI 10.1136/bmjopen-2021-059464
  2. Six-month outcomes after a GP phone call during the first French COVID-19 lockdown (COVIQuest): a cluster randomised trial using medico-administrative databases.
    Sauvage A, Laurent E, Giraudeau B, Tassi MF, et al · · 2024 · PMID 39581719 · DOI 10.1136/bmjopen-2024-085094

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other University Hospital, Tours trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04359875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing